Phase Forward Acquires Maaguzi

7/27/09

Phase Forward (NASDAQ: PFWD), the Waltham, MA-based maker of software used by pharmaceutical companies to manage data collection and analysis during clinical trials, said today that it has acquired Indianapolis, IN-based Maaguzi for $11 million in cash. Maaguzi operates a Web-based service used to collect data reported directly by patients. Phase Forward also reported today that its second-quarter revenues of $52.5 million were up 29 percent over Q208 levels.

Wade Roush is Chief Correspondent and Editor At Large at Xconomy. You can subscribe to his Google Group or e-mail him at wroush@xconomy.com. Follow @

By posting a comment, you agree to our terms and conditions.